Small-molecule complement inhibitors cannot prevent the development of the platelet storage lesion

Transfusion

Volumn 48, Issue 4, 2008, Pages 706-714

  Bradley, Amanda J ^a   Read, Brandi L ^a   Levin, Elena ^a   Devine, Dana V ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT INHIBITOR; COMPSTATIN; LIPOCORTIN 5; N ACETYLASPARTYLGLUTAMIC ACID; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL VIABILITY; COMPLEMENT INHIBITION; DRUG EFFECT; HUMAN; MORPHOLOGY; PROTEIN BINDING; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE PRESERVATION;

APOPTOSIS; BLOOD PLATELETS; BLOOD PRESERVATION; CASPASE 3; CELL SURVIVAL; DIPEPTIDES; ENZYME ACTIVATION; HUMANS; PEPTIDES, CYCLIC; PLATELET FUNCTION TESTS;

EID: 41149134550     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01595.x     Document Type: Article

References (36)

1. Seghatchian J, Krailadsiri P. The platelet storage lesion. Transfus Med Rev 1997 11 : 130 44.
2. Chernoff A, Snyder EL. The cellular and molecular basis of the platelet storage lesion: a symposium summary. Transfusion 1992 32 : 386 90.
3. Kaufman RM. Platelets: testing, dosing and the storage lesion - recent advances. Hematology 2006 : 492 6.
4. Fijnheer R, Modderman PW, Veldman H, Ouwehand WH, Nieuwenhuis HK, Roos D, de Korte D. Detection of platelet activation with monoclonal antibodies and flow cytometry. Changes during platelet storage. Transfusion 1990 30 : 20 5.
5. Rinder HM, Snyder EL. Activation of platelet concentrate during preparation and storage. Blood Cells 1992 18 : 445 60.
6. George JN, Pickett EB, Heinz R. Platelet membrane glycoprotein changes during the preparation and storage of platelet concentrates. Transfusion 1988 28 : 123 6.
7. Kunicki TJ, Tuccelli M, Becker GA, Aster RH. A study of variables affecting the quality of platelets stored at room temperature. Transfusion 1975 15 : 414 21.
8. Shapira S, Friedman Z, Shapiro H, Presseizen K, Radnay J, Ellis MH. The effect of storage on the expression of platelet membrane phosphatidylserine and the subsequent impact on the coagulation function of stored platelets. Transfusion 2000 40 : 1257 63.
9. Kilkson H, Holme S, Murphy S. Platelet metabolism during storage of platelet concentrates at 22 degrees C. Blood 1984 63 : 406 14.
10. Bode AP, Miller DT. Metabolic status of platelet concentrates during extended storage: improvement with pharmacological inhibitors and reduced surface-to-volume ratio. Vox Sang 1989 57 : 19 24.
11. Li J, Xia Y, Bertino AM, Coburn JP, Kuter DJ. The mechanism of apoptosis in human platelets during storage. Transfusion 2000 40 : 1320 9.
12. Rinder HM, Murphy M, Mitchell JG, Stocks J, Ault KA, Hillman RS. Progressive platelet activation with storage: evidence for shortened survival of activated platelets after transfusion. Transfusion 1991 31 : 409 14.
13. AuBuchon JP, Herschel L, Roger J, Murphy S. Preliminary validation of a new standard of efficacy for stored platelets. Transfusion 2004 44 : 36 41.
14. Dumont LJ, AuBuchon JP, Whitley P, Herschel LH, Johnson A, McNeil D, Sawyer S, Roger JC. Seven-day storage of single donor platelets: recovery and survival in an autologous transfusion study. Transfusion 2002 42 : 847 54.
15. Solheim BG, Flesland O, Seghatchian J, Brosstad F. Clinical implications of red blood cell and platelet storage lesions: an overview. Transfus Apher Sci 2004 31 : 185 9.
16. Seghatchian J. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers. Transfus Apher Sci 2006 34 : 125 30.
17. Gyongyossy-Issa MI, McLeod EM, Devine DV. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets. J Lab Clin Med 1994 123 : 859 68.
18. Miletic VD, Popovic O. Complement activation in stored platelet concentrates. Transfusion 1993 33 : 150 4.
19. Bode AP, Miller DT, Newman SL, Castellani WJ, Norris HT. Plasmin activity and complement activation during storage of citrated platelet concentrates. J Lab Clin Med 1989 113 : 94 102.
20. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988 263 : 18205 12.
21. 2+-initiated activation of cellular protein kinases. J Biol Chem 1987 262 : 13674 81.
22. Holland MC, Morikis D, Lambris JD. Synthetic small-molecule complement inhibitors. Curr Opin Invest Drugs 2004 5 : 1164 73.
23. Etievant M, Leluc B, David B. In vitro inhibition of the classical and alternate pathways of activation of human complement by N-acetyl aspartyl glutamic acid (NAAGA). Agents Action 1988 24 : 137 44.
24. Sahu A, Soulika AM, Morikis D, Spruce L, Moore WT, Lambris JD. Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin. J Immunol 2000 165 : 2492 9.
25. Soulika AM, Holland MC, Sfyroera G, Sahu A, Lambris JD. Compstatin inhibits complement activation by binding to the β-chain of complement factor 3. Mol Immunol 2006 43 : 2023 9.
26. Katragadda M, Morikis D, Lambris JD. Thermodynamic studies on the interaction of the third complement component and its inhibitor, compstatin. J Biol Chem 2004 279 : 54987 95.
27. Nilsson B, Larsson R, Hong J, Elgue G, Ekdahl KN, Sahu A, Lambris JD. Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation. Blood 1998 92 : 1661 7.
28. Fiane AE, Mollnes TE, Videm V, Hovig T, Høgåsen K, Mellbye OJ, Spruce L, Moore WT, Sahu A, Lambris JD. Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts. Xenotransplantation 1999 6 : 52 65.
29. Soulika AM, Khan MM, Hattori T, Bowen FW, Richardson BA, Hack CE, Sahu A, Edmunds LH, Lambris JD. Inhibition of heparin/protamine complex-induced complement activation by compstatin in baboons. Clin Immunol 2000 96 : 212 21.
30. Katragadda M, Magotti P, Sfyroera G, Lambris JD. Hydrophobic effect and hydrogen bonds account for the improved activity of a complement inhibitor, compstatin. J Med Chem 2006 49 : 4616 22.
31. Devine DV, Bradley AJ, Maurer E, Levin E, Chahal S, Serrano K, Gyongyossy-Issa MI. Effects of prestorage white cell reduction on platelet aggregate formation and the activation state of platelets and plasma enzyme systems. Transfusion 1999 39 : 724 34.
32. Bertolini F, Rebulla P, Porretti L, Murphy S. Platelet quality after 15-day storage of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium. Transfusion 1992 32 : 9 16.
33. Sweeney J, Kouttab N, Holme S, Kurtis J, Cheves T, Nelson E. Storage of platelet-rich plasma-derived platelet concentrate pools in plasma and additive solution. Transfusion 2006 46 : 835 40.
34. Hornsey VS, McColl K, Drummond O, McMillan L, Morrison A, Morrison L, MacGregor IR, Prowse CV. Extended storage of platelets in SSP platelet additive solution. Vox Sang 2006 91 : 41 6.
35. Leytin V, Freedman J. Platelet apoptosis in stored platelet concentrates and other models. Transfus Apher Sci 2003 28 : 285 95.
36. Bertino AM, Qi XQ, Li J, Xia Y, Kuter DJ. Apoptotic markers are increased in platelets stored at 37°C. Transfusion 2003 43 : 857 66.